"Nicotine could maintain or restore the function of the cholinergic anti-inflammatory system and thus control the release and activity of pro-inflammatory cytokines. This could prevent or suppress the cytokine storm. This hypothesis needs to be examined in the laboratory and the clinical setting."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192087/#!po=22...
I have a very rare immune mediated neurological disease affecting nicotinic receptors in my peripheral nervous system called autoimmune autonomic gangliopathy.
I am ganglionic nicotinic acetylcholine receptor antibody (nAChR, α3 subunit) positive, at high and abnormal levels, which means this antibody blocks signals at the ion channel level, in my neurons of my autonomic ganglia, which is supposed to control bodily functions—but it malfunctions in my body. Some people with the disease I have, (supposedly ~22% according to this PMC article on PUBMED: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536520/) have alpha7 subunit nicotinic acetylcholine receptor antibodies (α7 nAChR antibodies), which effectively block signals in general, affecting transmission of signals via the ion channels of neurons in the central nervous system. This type of central nervous system blockade of the autonomic nervous system causes inflammation.
The article that the above poster linked is an ominous warning for people like me, who have the same very rare disease I have, even if one is just alpha3 nAChR antibody positive only—and is not also alpha7 nAChR antibody positive. I am glad I have been taking extreme steps to protect myself.
Also, some people that never recovered from COVID-19 have sympathetic nervous activity have similarities to the condition I have.
Researchers may want to search for autoimmune autonomic ganglionopathy on PUBMED: https://pubmed.ncbi.nlm.nih.gov/?term=Autoimmune+autonomic+g...
You also may want to search for autoimmune autonomic ganglionopathy and the alpha7 nAChR on PUBMED: https://pubmed.ncbi.nlm.nih.gov/?term=Autoimmune+autonomic+g...
Or α7 nAChR antibodies, which in theory would have a similar but different effect as the stuff that the poster above me linked: https://pubmed.ncbi.nlm.nih.gov/?term=%CE%B17+NAChR+antibodi...
As for the people who have a post COVID-19 inflammatory syndrome affecting their sympathetic (as in autonomic nervous system) nervous system, as in sympathetic over activity, they very likely have a form of dysautonomia:
Researchers may want to look into these antibodies/tests, in which there are several peer reviewed articles available to read. However, several of these tests are not commercially available in the US, but can be mailed/performed in Germany. See: https://www.celltrend.de/en/pots-cfs-me-crps.html
There is an immune mediated dysautonomia panel available at the Mayo Clinic (which I was found to have one of the antibodies), but one is far less likely to test positive for something in these screens. See this panel: https://www.mayocliniclabs.com/test-catalog/Overview/92121
A lot of this immune mediated autonomic nervous system stuff is just starting to emerge and come to fruition.
> Conclusions and relevance: Our cross sectional study in both COVID-19 out- and inpatients strongly suggests that daily smokers have a very much lower probability of developing symptomatic or severe SARS-CoV-2 infection as compared to the general population.
> Very recently, the US Center of Disease Control reported an analysis of current smoker rate among US COVID-19 patients which was found to be 1.3% for the whole population of COVID-19 patients, 1% for outpatients, 2% for patients, not hospitalized in an ICU, and 1% in intensive care unit (ICU)-admitted patients
https://www.qeios.com/read/WPP19W.3
in all of the mentioned countries, only about 1% of ICU cases are smokers. this has (perhaps unsurprisingly) not been widely reported.
Being a smoker has been a standard part of your medical history for a long time now for obvious reasons. There's no reason to think there is a coordinated strategy for lying about smoking in the context of a pandemic (much less revising patient medical histories, which would be the medical service industry lying).
50%+ lying about smoking in the face of potential (or actual) respiratory failure is laughable.
I don't know where you got 50%+. The outpatient group was 5.3% current smokers vs expected (adjusted for age and sex) 26.9%. For inpatient it was 4.4% vs expected 17.9%. The fact that both groups had the same reported rate of current smokers (within experimental error) but very different expected rates says to me that you're only getting the people who are honest or simply incapable of quitting even while sick.
Also, see this concern brought up:
> Finally, and I believe this to be the most significant piece of data supporting the null hypothesis, the prevalence of never-smokers in the general population is approximately 0.75, if one subtracts the smoking incidence rate from 100. In your patient groups, non-smokers are strongly under-represented by about a factor of 2 relative to the general population, with 31% of outpatient and 32% of inpatient being labeled as never-smokers. This suggests to me that any amount of smoking actually puts one at risk for contracting COVID-19 as defined by this paper.
In any case, many other studies of COVID-19 have found similar results, and studies of different respiratory diseases have not. I'd initially just thought people were lying too, but at some point the evidence becomes overwhelming--if the protective behavior were anything but smoking, then people would have accepted it long ago.
Of course smoking is far deadlier on average than the coronavirus, per my calculation elsewhere in this thread. No one should start smoking because of this, but I do see enough evidence e.g. that a nursing home patient (who's at very high risk of death from coronavirus, and likely to die of something else before smoking-related diseases could develop) shouldn't quit. Vaping probably gets any benefit with almost none of the health risk, though that's speculative.
1. http://beh.santepubliquefrance.fr/beh/2019/15/pdf/2019_15_1....
Seriously though, it's baffling because smoking causes so many underlying health problems that don't go well with COVID. Also, smokers have a depressed immune system compared to nonsmokers, so it would seem to suggest they'd be less likely to fight off an infection like this.
>smokers with a positive Covid-19 test were more than twice as likely as non-smokers with coronavirus to be hospitalised.
> This aligns with research from the US which found hospitalised smokers with coronavirus were 1.8 times more likely to die.
is contradicted by the study showing that smokers with covid are more likely to have severe symptoms than non-smokers with covid.
While a lot of people are skeptical of the official numbers from these countries, I think they have free media and if cases were high, we would have known.
If most people that have severe COVID complications and end up on the ICU are aged 80+, and generally smokers die before that age from smoking-related complications, doesn't it naturally follow that most people on the ICU will be non-smokers? Smoking will have killed the smokers before they become part of the high-risk group, after all.
Here is a quote from the abstract of the paper linked above:
> Results: The inpatient group was composed of 343 patients, median age 65 yr: 206 men (601%, median age 66 years) and 137 women (39.9%, median age 65 years) with a rate of daily smokers of 4.4% (5.4% of men and 2.9% of women).The outpatient group was composed of 139 patients, median age 44 years: 62 men (44.6 %, median age 43 years, and 77 women (55.4 %, median age 44 years). The daily smokers rate was 5.3% (5.1% of men and 5.5 % of women). In the French population, the daily smokers rate was 25.4% (28.2% of men and 22.9% of women).
The average daily smoker rate is taken as-is over the whole population, and compared to the smoking rate of people of age around ~66 years, despite the article itself stating that the percentage of daily smokers is lower for old people and higher for young people.
So already in the abstract they have made a mistake and forgot to correct for age. I have not read the rest of the article in enough depth to judge fully, but I would absolutely not blindly trust researchers to always do this correction in an appropriate way.
They also said elsewhere that a lot of researchers from outside epidemiology are running really bad studies and publishing papers.
Even with conservative assumptions, smokers in this French study were 4 to 5 times less likely to be infected.
Keep in mind that drugs being tested are considered good when they reduce mortality by 10%. We're talking 75% reduction in infection rate here, and no increased mortality in those who are infected. It's really really hard to imagine what sort of confounding factor that could be at play here that would make the effect insignificant.
They give nicotine patches to nurses in pilot studies, how ironical :D
Edit: I had that wrong, it seems nicotine increases ACE2, but also binds with ACE2 decreasing the amount of available enzymes overall that COVID could bind to.[2]
[0]https://en.wikipedia.org/wiki/Angiotensin-converting_enzyme_... [1]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191112/ [2]https://arxiv.org/abs/2004.14943
Vaping is less clear--I do think there's some non-negligible chance that for the next couple years, it will be a net benefit to public health. That would be funny, considering how hard the public health authorities worked to smear nicotine vaping with the deaths from adulterated (vitamin E acetate) marijuana cartridges last summer.
https://www.nature.com/articles/s41591-020-0968-3
To quote this paper's author: "This virus is unusual and it's hard not to take a step back and not be impressed by how many manifestations it has on the human body"
and to quote the paper itself: "In a study of nearly 5,500 patients admitted with COVID-19 in a New York City hospital system, (acute kidney injury) occurred in 37%, with 14% of the patients requiring dialysis. "
and that is only one of dozens of conditions in their findings.
The average IFR over all ages is 0.7%[4] from a recent meta-analysis. If we're considering prospective smokers, then I guess we should exclude young children, so let's (again, somewhat arbitrarily) bump that up to 1%. That would mean a coronavirus infection in a random individual (age weighted according to population of prospective smokers) costs 0.1 years of life expectancy.
But smokers have life expectancy about ten years[5] shorter than non-smokers! So there's lots you could find to argue about in my rough calculation above, and I agree that patients who don't die immediately still lose some yet-unknown number of quality-adjusted years of life; but unless you think you can find two orders of magnitude, smoking is unquestionably more dangerous. That doesn't mean the coronavirus is harmless, just that smoking is really bad.
1. https://www.cdc.gov/mmwr/volumes/69/wr/mm6928e1.htm
2. https://www.ssa.gov/oact/STATS/table4c6.html
3. https://www.ucsf.edu/news/2010/08/98172/social-support-key-n...
4. https://www.medrxiv.org/content/10.1101/2020.05.03.20089854v...
5. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/heal...
By "net benefit", you mean because it can help people quit actual smoking, right?
Of course vaping's real benefit to public health comes from smoking cessation as you say, since smoking is (per my comment above) really deadly. I was disturbed to see the public health authorities blaming nicotine vaping for the lung injuries last summer, given (a) the ample evidence for vitamin E acetate as the cause; and (b) the cost in mortality from smokers who got scared by their misleading warnings and either didn't switch to vaping or switched back to cigarettes.
Mildly OT, but, don't depend on popular news to get you the important info of the world.
https://www.who.int/news-room/commentaries/detail/smoking-an...
> smokers with a positive Covid-19 test were more than twice as likely as non-smokers with coronavirus to be hospitalised.
>This aligns with research from the US which found hospitalised smokers with coronavirus were 1.8 times more likely to die.
501 karma for downvoting
I can downvote but rarely do it. Also a comment can only be downvoted 4 times. After that downvotes are not counted anymore if I remember correctly.
But I don't remember anything lower than that recently, so it can be a new change.
The people dropping dead in the streets, like we saw so much of in Wuhan (smoking population ~50%)-- those are the smokers. Smoking opens up more ACE2 receptors which is like opening more lanes for COVID traffic.
I'm reluctant to recommend quitting
Quit now!
Edit: I googled it, because someone downvoted it me so I guess they didn't appreciate me being lazy.
https://www.healthing.ca/diseases-and-conditions/coronavirus...
https://www.webmd.com/lung/news/20200430/smokers-hospitalize...
> "One hypothesis is that nicotine, which has anti-inflammatory properties, may interfere with the way that COVID-19 causes an overreaction of the immune system."